Evidence map›Paper›PMID 23723152›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2013

Site-directed zebrafish transgenesis into single landing sites with the phiC31 integrase system.

Christian Mosimann, Ann-Christin Puller, Katy L Lawson, Patrick Tschopp, Adam Amsterdam, Leonard I Zon

Open access · bronzeAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cp36 serine recombinase as a new tool for zebrafish transgenesis.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Science advances · 2024
    Article
  11. Selective Cell Ablation Using an Improved Prodrug-Converting Nitroreductase.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  12. Review
  13. bioRxiv : the preprint server for biology · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Heterogeneity and genomic loci of ubiquitous transgenic Cre reporter lines in zebrafish.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Article
  19. Zebrafish Models of Paediatric Brain Tumours.International journal of molecular sciences · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Christian Mosimann *Howard Hughes Medical Institute, Boston, MA 02115, USA.
Ann-Christin Puller *Howard Hughes Medical Institute, Boston, MA 02115, USA.
Katy L LawsonHoward Hughes Medical Institute, Boston, MA 02115, USA.
Patrick TschoppDepartment of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Adam AmsterdamKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02319, USA.
Leonard I ZonHoward Hughes Medical Institute, Boston, MA 02115, USA.
Harvard University · USBoston Children's Hospital · USHarvard Stem Cell Institute · USHoward Hughes Medical Institute · USMassachusetts Institute of Technology · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
CORE--ZEBRAFISHP30DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1999 to 2015
$14.3M
EMBRYONIC HEMATOPOIESISR01HL048801 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1992 to 2016
$5.7M
Howard Hughes Medical InstituteNHLBI NIH HHS 5P01HL32262-28NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL048801NIDDK NIH HHS P30 DK049216
6 · The paper itself

Abstract

backgroundLinear DNA-based and Tol2-mediated transgenesis are powerful tools for the generation of transgenic zebrafish. However, the integration of multiple copies or transgenes at random genomic locations complicates comparative transgene analysis and makes long-term transgene stability unpredictable with variable expression. Targeted, site-directed transgene integration into pre-determined genomic loci can circumvent these issues. The phiC31 integrase catalyzes the unidirectional recombination reaction between heterotypic attP and attB sites and is an efficient platform for site-directed transgenesis.

resultsWe report the implementation of the phiC31 integrase-mediated attP/attB recombination for site-directed zebrafish transgenics of attB-containing transgene vectors into single genomic attP landing sites. We generated Tol2-based single-insertion attP transgenic lines and established their performance in phiC31 integrase-catalyzed integration of an attB-containing transgene vector. We found stable germline transmission into the next generation of an attB reporter transgene in 34% of all tested animals. We further characterized two functional attP landing site lines and determined their genomic location. Our experiments also demonstrate tissue-specific transgene applications as well as long-term stability of phiC31-mediated transgenes.

conclusionsOur results establish phiC31 integrase-controlled site-directed transgenesis into single, genomic attP sites as space-, time-, and labor-efficient zebrafish transgenesis technique. The described reagents are available for distribution to the zebrafish community.

Indexed as

Gene Transfer TechniquesAnimalsAnimals, Genetically ModifiedIntegrasesZebrafishZebrafish ProteinsIntegrasesZebrafish ProteinsgeneticsphiC31transgenesiszebrafish

Identifiers

PMID23723152
PMCPMC3775328
OpenAlexW1487954664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.